USE OF A MARKER SET FOR DETERMINING THE RISK OF KIDNEY REJECTION

Provided is an in vitro method for determining the risk of kidney rejection of an individual after having obtained a kidney donation using a marker set including at least three substances chosen from the group consisting of 3-hydroxy isovalerate, acetyl carnitine, alanine, citrate, dimethylamine, gl...

Full description

Saved in:
Bibliographic Details
Main Authors NEUMANN, Sindy, EIGLSPERGER, Johannes, PFAHLERT, Volker, ZUCKER, Maximilian, PAGEL, Philipp
Format Patent
LanguageEnglish
French
German
Published 22.01.2020
Subjects
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:Provided is an in vitro method for determining the risk of kidney rejection of an individual after having obtained a kidney donation using a marker set including at least three substances chosen from the group consisting of 3-hydroxy isovalerate, acetyl carnitine, alanine, citrate, dimethylamine, glucose, glucuronate, hippurate, lactate, malonate, methyl guanidine, methyl malonate, methyl succinate, p-cresol, phenyl acetate, phenylacetylglycine, phenylacetylglutamine, taurine, trigonelline, and urea. The marker set also includes at least one substance chosen from the group consisting of alanine, dimethylamine, glucuronate, phenylacetylglutamine, and urea.
Bibliography:Application Number: EP20180714723